Publication:
An efficient separation and method development for the quantifying of two basic impurities of Nicergoline by reversed-phase high performance liquid chromatography using ion-pairing counter ions

dc.contributor.authorsYalcin, Guler; Yuktas, F. Nuray
dc.date.accessioned2022-03-12T17:19:11Z
dc.date.accessioned2026-01-11T08:01:47Z
dc.date.available2022-03-12T17:19:11Z
dc.date.issued2006
dc.description.abstractA quantification method was developed for the two basic impurities, one of which is also a metabolite, of Nicergoline (NIC), by using reversed-phase high performance liquid chromatography (RP-HPLC) and diode array detector (DAD). One of these compounds, 10-methoxy-6-methylergoline-8 beta-methanol-5-bromo-3-pyridinecarboxylate (1-DN) is the metabolite as well as the impurity whereas, the other 10-methoxy-1,6-dimethylergoline-8 beta-methanol-5-chloro-3-pyridinecarboxylate (5-CN) is only an impurity. The chromatographic column was Phenomenex, Luna, 5 mu m, C 18 (2), 250 mm x 4.6 mm. Mobile phase was 0.1 M ammonium acetate (NH4Ac) solution containing 4 mM 1-octanesulfonicacid sodium salt (OSASS) and 6 mM tetrabutylammonium hydrogen sulphate (TBAHS) (pH: 5.9)/acetonitrile (ACN) (62:38) for 1-DN and (64:36) for 5-CN. Flow rate was 1.0 mL min(-1). The diode array detector was operated at 285 nm, band width: 4 nm. Linearity was obtained in the concentration range of 0.032 x 10(-5) to 3.828 x 10(-5) M, y = 116.88x + 0.2773 (r(2) = 0.99989); the limit of detection (LOD) and limit of quantification (LOQ) were determined as 0.012 x 10(-5) and 0.041 x 10(-5) M for 1-DN, respectively. Linearity was obtained in the concentration range of 0.034 x 10(-5) to 4.092 x 10(-5) M, y = 104.24x + 0.7486 (r(2) = 0.99996); (LOD) and (LOQ) were determined as 0.014 x 10(-5) and 0.046 x 10(-5) M for 5-CN, respectively. The recovery was 100.65% for 1-DN and 100.32% for 5-CN. The amount of 1-DN in 30 mg NIC was found as 209.65 mu g (0.70%) and the amount of 5-CN in 30 mg NIC was found as 27.62 mu g (0.09%). (c) 2006 Elsevier B.V. All rights reserved.
dc.identifier.doi10.1016/j.jpba.2006.04.032
dc.identifier.issn0731-7085
dc.identifier.pubmed16766155
dc.identifier.urihttps://hdl.handle.net/11424/228071
dc.identifier.wosWOS:000241125900005
dc.language.isoeng
dc.publisherPERGAMON-ELSEVIER SCIENCE LTD
dc.relation.ispartofJOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectNicergoline
dc.subjectbasic impurities
dc.subjectquantification
dc.subjection pairing counter ions
dc.subjectreversed-phase HPLC
dc.subjectPOLYBUTADIENE-COATED ZIRCONIA
dc.subjectSILANE BONDED SILICA
dc.subjectIONIZATION MASS-SPECTROMETRY
dc.subjectSTATIONARY PHASES
dc.subjectRETENTION MECHANISM
dc.subjectDRUGS
dc.subjectAMINES
dc.subjectPHARMACEUTICALS
dc.subjectMETABOLITES
dc.subjectSUBSTANCES
dc.titleAn efficient separation and method development for the quantifying of two basic impurities of Nicergoline by reversed-phase high performance liquid chromatography using ion-pairing counter ions
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage440
oaire.citation.issue4
oaire.citation.startPage434
oaire.citation.titleJOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
oaire.citation.volume42

Files